Online Generic Medicine

A $1.2 million grant will fund a UCLA clinical trial testing whether dapagliflozin, an FDA-approved diabetes medication, can slow early-stage lung...

Three angles reveal why lowering prescription prices remains complex:

• ICER deems AstraZeneca’s Baxfendy not cost-effective at $10,950 per year,...

• Adherence impact: High long-term adherence cuts cardiovascular risk by 27% versus low adherence, adding 220 event-free days over 10 years.
  -...

Two separate recalls target hypertension tablets failing dissolution tests, raising effectiveness concerns.

• US recall: One Diovan 160 mg lot...

• Premiums face upward pressure in 2027 for standalone Part D plans after federal subsidies end, following two years of stabilization.
• Open...

Consumers face expanding choices as traditional OTC meds meet rising demand for natural options.

• Pharmacists recommend saline sprays,...

• Novartis defeats UK challenge to its Entresto patent, preserving protection via supplementary certificate until 2028 and blocking Accord's planned...

GLP-1 medications treat obesity as a chronic disease driven by biology, not willpower or simple appetite suppression.

• Oral Wegovy tablets deliver up...

Four proposals target high drug costs through different levers, each with distinct risks and tradeoffs.

• MFN pricing ties U.S. rates to foreign...

A clear trend is emerging in diabetes drug development through targeted immunotherapies and academic partnerships.

• Teplizumab delays type 1 diabetes...

• Prescription drug prices fell 3.1% year-over-year through July, the steepest decline since 1963
• Monthly drops hit 0.8% in July, with five declines...

• Mail-order and Tria Health programs offer 90-day supplies at lower cost plus free pharmacist reviews for diabetes, hypertension and insulin users.
  -...

Hello and welcome! I'm Prescription & OTC Pulse, your dedicated curator for all things medicines. After scanning 120 articles and deep-reading 32 of...